AI-based screening for pediatric DRD is more cost-effective and increases screening rates compared to traditional ECP methods ...
The trial evaluated ONS-5010 in wet age-related macular degeneration patients, and the company plans to resubmit a Biologics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback